Articles dans des revues avec comité de lecture (10)
  1. 1. Roca Rivada, A., Marin Canas, S., Colli, M. L., Vinci, C., Sawatani, T., Marselli, L., Cnop, M., Marchetti, P., & Eizirik, D. L. (2023). Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-α-induced human beta cell dysfunction and death. Diabetologia, 66(8), 1544-1556. doi:10.1007/s00125-023-05908-5
  2. 2. Gonzalez-Moro, I., Garcia-Etxebarria, K. G.-E. K., Mendoza, L. M. M. L., Fernández-Jiménez, N. F., Mentxaka, J. M., Olazagoitia-Garmendia, A., Arroyo, M. N., Sawatani, T., Moreno Castro, C., Vinci, C., Op De Beeck, A., Cnop, M., Igoillo Esteve, M., & Santin, I. (2023). LncRNA ARGI Contributes to Virus-Induced Pancreatic β Cell Inflammation Through Transcriptional Activation of IFN-Stimulated Genes. Advanced Science. doi:10.1002/advs.202300063
  3. 3. Strollo, R., Vinci, C., Man, Y. K. S., Bruzzaniti, S., Piemonte, E., Alhamar, G., Briganti, S. I., Malandrucco, I., Tramontana, F., Fanali, C., Garnett, J., Buccafusca, R., Guyer, P., Mamula, M. M., James, E. E., Pozzilli, P., Ludvigsson, J., Winyard, P., Galgani, M., & Nissim, A. (2022). Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes. Diabetologia. doi:10.1007/s00125-022-05812-4
  4. 4. Fantuzzi, F., Toivonen, S., Schiavo, A. A., Chae, H., Tariq, M., Sawatani, T., Pachera, N., Cai, Y., Vinci, C., Virgilio, E., Ladrière, L., Suleiman, M., Marchetti, P., Jonas, J.-C. J., Gilon, P., Eizirik, D. L., Igoillo Esteve, M., & Cnop, M. (2022). In depth functional characterization of human induced pluripotent stem cell-derived beta cells in vitro and in vivo. Frontiers in Cell and Developmental Biology, 10. doi:10.3389/fcell.2022.967765
  5. 5. Vinci, C., Infantino, M., Raturi, S., Tindell, A., Topping, L. M., Strollo, R., Amital, H., Shoenfeld, Y., Gertel, S., Grossi, V., Manfredi, M., Rutigliano, I. M., Bandinelli, F., Li Gobbi, F., Damiani, A., Pozzilli, P., Mcinnes, I. B., Goodyear, C. S., Benucci, M., & Nissim, A. (2020). Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritis. Scandinavian journal of rheumatology, 49(4), 281-291. doi:10.1080/03009742.2020.1713395
  6. 6. Topping, L. L., Thomas, B. L., Rhys, H. H., Tremoleda, J. J., Foster, M., Seed, M., Voisin, M.-B., Vinci, C., Law, H. L., Perretti, M., Norling, L. L., Azevedo, H. S., & Nissim, A. (2020). Targeting Extracellular Vesicles to the Arthritic Joint Using a Damaged Cartilage-Specific Antibody. Frontiers in immunology, 11, 10. doi:10.3389/fimmu.2020.00010
  7. 7. Jühlen, R., Martinelli, V., Vinci, C., Breckpot, J., & Fahrenkrog, B. (2020). Centrosome and ciliary abnormalities in fetal akinesia deformation sequence human fibroblasts. Scientific reports, 10(1), 19301. doi:10.1038/s41598-020-76192-1
  8. 8. Strollo, R., Vinci, C., Napoli, N., Fioriti, E., Maddaloni, E., Åkerman, L., Casas, R., Pozzilli, P., Ludvigsson, J., & Nissim, A. (2019). Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies. Diabetes/metabolism research and reviews, 35(4), e3132. doi:10.1002/dmrr.3132
  9. 9. Strollo, R., Vinci, C., Napoli, N., Pozzilli, P., Ludvigsson, J., & Nissim, A. (2017). Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children. Diabetologia, 60(8), 1467-1474. doi:10.1007/s00125-017-4296-1
  10. 10. Strollo, R., Vinci, C., Arshad, M. H., Perrett, D., Tiberti, C., Chiarelli, F., Napoli, N., Pozzilli, P., & Nissim, A. (2015). Antibodies to post-translationally modified insulin in type 1 diabetes. Diabetologia, 58(12), 2851-2860. doi:10.1007/s00125-015-3746-x
    11.   Participations à des congrès et colloques internationaux (2)
  11. 1. Arroyo, M. N., Santacreu, B. J., Green, J., Mentxaka, J., Sawatani, T., Pachera, N., Fantuzzi, F., Vinci, C., Tong, Y., Gevaert, K., Regazzi, R., Cnop, M., Op de Beek, A., Santin, I., & Igoillo Esteve, M. (2022). TRMT10A deficiency-induced 5'-tRNAGln fragments modulate gene expression in pancreatic beta-cells. Paper session presented at 28th tRNA Conference (12-16 June 2022: The Ohio State University, Ohio. USA.).
  12. 2. Arroyo, M. N., Santacreu, B. J., Green, J., Cosentino, C., Mentxaka, J., Sawatani, T., Pachera, N., Fantuzzi, F., Vinci, C., Tong, Y., Gevaert, K., Regazzi, R., Cnop, M., Op de Beek, A., Santin, I., & Igoillo Esteve, M. (2022). TRMT10A deficiency-induced 5’-tRNAGln fragments lead to β-cell demise in rare and common forms of diabetes. Paper session presented at Study Group on the Genetics of Diabetes 2022 (2022: Lille, France).